Mycolixin Cream

Natural health product licensed in Canada

Oral dose analysis does not apply without an established exclusively oral route.

Composition

Medicinal composition not provided.

Parfum, Cétomacrogol 1 000, Huile de paraffine, Pétrolatum blanc, Eau purifiée, Phénoxyéthanol, Alcool cétostéarylique

Population	Age	Quantity per serving	Frequency
Adultes	Not specified	1 Crème	2 Tous les jours
Adolescentes	minimum: 12 years ; maximum: 17 years	1 Crème	2 Tous les jours

Helps reduce the severity of tinea skin conditions.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Effets indésirables connus
There is an extremely low risk of skin irritation or mild local allergic reaction. If this does occur, treatment should be ceased immediately. Consult your health care practitioner if symptoms persist.
Contre-indications
The cream should not be used in cases of known hypersensitivity to any of the ingredients in the formulation. To test for hypersensitivity, apply a small amount to the inside of the wrist.
Précautions et mises en garde
For external use only. If symptoms worsen or persist, consult a health care practitioner. If you are pregnant and/or breastfeeding consult a health care practitioner prior to use. Avoid contact with eyes and mucous membranes; if this happens, rinse thoroughly with water.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.